Your Health, We Care

Home >Drug List>Acalabrutinib>Indications of Acalabrutinib

Acalabrutinib(LuciAcal)

Release date: 2026-01-05 14:42:43     Recommended: 178

It is indicated for the treatment of adult patients with mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL).